October 05, 2026 03:22 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
'If law wasn't followed, we can undo it': Supreme Court's big warning on SIR process amid Gyanesh Kumar row | From TMC Rajya Sabha MP to BJP nominee in 6 months: Koel Mallick's stunning political U-turn | ‘Stomp on your head’: Omani flydubai co-pilot’s chilling posts on violence against women surface | Asian Games 2026: India beat Pakistan to clinch gold in men's cricket | flydubai cockpit attack: Deleted posts expose Omani co-pilot’s views on women, alleged extremist past | flydubai cockpit horror: Omani co-pilot Hamam al-Hammami attacked Captain Smit Machchhar with crash axe, tried to seize control | flydubai temporarily suspends all Israel flights after co-pilot’s alleged cockpit attack, crash attempt | Grounded in Oman over ‘radical views’, then hired by flydubai: What we know about Omani pilot Hamam al-Hammami | ‘Hanuman Chalisa gave me courage’: Smit Machchhar recounts flydubai cockpit battle to PM Modi | PM Modi speaks to Flydubai pilot Smit Machchhar who foiled crash plot, praises his courage

Philippines healthcare providers administer vaccine approved for prevention of Dengue

| | Feb 23, 2016, at 05:00 am
Kolkata/Lyon, Feb 22 (IBNS): Sanofi Pasteur, the vaccines division of Sanofi, announced on Monday that vaccinations with Dengvaxia have commenced in the Philippines following official receipt of the first shipment of the vaccine earlier this month.
Dengvaxia, a tetravalent dengue vaccine, was approved in the Philippines on 22 December 2015 for the prevention of disease caused by all four Dengue types in individuals from 9-45 years of age living in endemic areas. 
 
The vaccine is administered in three doses given over a one-year period. Asia bears 70% of dengue fever burden globally with an estimated 67 million people being sickened by the disease annually. 
 
In the Philippines alone, over 110,000 people on average get Dengue every year. Asian endemic countries spend an estimated 6.5 billion USD annually in both direct medical and indirect costs due to Dengue.
 
“This is truly a great moment in the history of vaccinology,” states Guillaume Leroy, Vice-President of Dengue Vaccine, Sanofi Pasteur. “Dengvaxia’s availability for administration by healthcare providers in the Philippines, to be followed closely by the initiation of a public sector immunization program in the country is a landmark event for global Dengue prevention and a great achievement for the people of the Philippines.”
 
Medical Societies in the Philippines held a media event in Manila earlier this month to welcome receipt of the first shipment of Dengvaxia to the country.
 
In attendance, Dr. Rose Capeding, chief of the Research Institute for Tropical Medicine’s department of microbiology, noted that the Philippines participated in all three phases of the clinical development of the vaccine and that healthcare providers there were delighted to be able to begin vaccinating against dengue, which continues to pose a major public health threat to the nation.
 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.